Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization. Issue 4 (25th March 2021)

• Record Type: Journal Article
• Authors: Braun, Hillary J.; Dodge, Jennifer L.; Grab, Joshua D.; Schwab, Marisa E.; Liu, Iris H.; Glencer, Alexa C.; Stock, Peter G.; Hirose, Ryutaro; Roberts, John P.; Ascher, Nancy L.
• Is Part Of: Transplantation. Volume 105:Issue 4(2021)
• Page Start: 824
• Page End: 831
• Publication Date: 2021-03-25
• Subjects: Transplantation of organs, tissues, etc -- Periodicals; Transplantation immunology -- Periodicals; 617.95
• DOI: 10.1097/TP.0000000000003318
• Languages: English
• ISSNs: 0041-1337

Abstract

Abstract : Background: Share 35 was a policy implemented in 2013 to increase regional sharing of deceased donor livers to patients with model for end-stage liver disease ≥ 35 to decrease waitlist mortality for the sickest patients awaiting liver transplantation (LT). The purpose of this study was to determine whether live donor liver transplantation (LDLT) volume was impacted by the shift in allocation of deceased donor livers to patients with higher model for end-stage liver disease scores. Methods: Using Network for Organ Sharing/Organ Procurement and Transplantation Network Standard Transplant Analysis and Research files, we identified all adults who received a primary LT between October 1, 2008, and March 31, 2018. LT from October 1, 2008, through June 30, 2013, was designated as the pre-Share 35 era and July 1, 2013, through March 31, 2018, as the post-Share 35 era. Primary outcomes included transplant volumes, graft survival, and patient survival in both eras. Results: In total, 48 779 primary adult single-organ LT occurred during the study period (22 255 pre-Share 35, 26 524 post). LDLT increased significantly (6.8% post versus 5.7% pre, P < 0.001). LDLT volume varied significantly by region ( P < 0.001) with regions 2, 4, 5, and 8 demonstrating significant increases in LDLT volume post-Share 35. The number of centers performing LDLT increased only in regions 4, 6, and 11. Throughout the 2 eras, there was no difference in graft or patient survival for LDLT recipients. Conclusions: Overall, LDLT volume increased following the implementation of Share 35, which was largely due to increased LDLT volume at centers with experience in LDLT, and corresponded to significant geographic variation in LDLT utilization.